Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Surface Oncology (SURF)

Surface Oncology Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SURF
DateTimeSourceHeadlineSymbolCompany
13/09/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SURFSurface Oncology Inc
13/09/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SURFSurface Oncology Inc
08/09/202321:10Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:SURFSurface Oncology Inc
08/09/202321:09Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:SURFSurface Oncology Inc
08/09/202321:08Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:SURFSurface Oncology Inc
08/09/202321:07Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:SURFSurface Oncology Inc
08/09/202321:06Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:SURFSurface Oncology Inc
08/09/202321:05Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:SURFSurface Oncology Inc
08/09/202321:04Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:SURFSurface Oncology Inc
08/09/202321:03Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:SURFSurface Oncology Inc
08/09/202321:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SURFSurface Oncology Inc
08/09/202321:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SURFSurface Oncology Inc
08/09/202321:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SURFSurface Oncology Inc
08/09/202321:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SURFSurface Oncology Inc
08/09/202321:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SURFSurface Oncology Inc
08/09/202314:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SURFSurface Oncology Inc
31/08/202322:18Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SURFSurface Oncology Inc
31/08/202321:01GlobeNewswire Inc.Surface Oncology Announces ISS and Glass Lewis Both Recommend Stockholders Vote “FOR” the Proposed Merger with Coherus BioSciencesNASDAQ:SURFSurface Oncology Inc
30/08/202321:34Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SURFSurface Oncology Inc
30/08/202321:32Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:SURFSurface Oncology Inc
30/08/202321:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SURFSurface Oncology Inc
12/08/202301:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SURFSurface Oncology Inc
12/08/202301:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SURFSurface Oncology Inc
12/08/202301:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SURFSurface Oncology Inc
02/08/202312:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SURFSurface Oncology Inc
02/08/202312:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SURFSurface Oncology Inc
02/08/202312:00GlobeNewswire Inc.Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2023NASDAQ:SURFSurface Oncology Inc
26/07/202321:56Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:SURFSurface Oncology Inc
20/07/202313:00Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SURFSurface Oncology Inc
12/07/202322:08Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:SURFSurface Oncology Inc
 Showing the most relevant articles for your search:NASDAQ:SURF